Sonnet BioTherapeutics Holdings, Inc. (SONN) Dividend History

Company News

• Sonnet Chief Medical Officer, Richard Kenney, M.D., to Present at the 6th Annual Cytokine-Based Drug Development Summit

  Sonnet BioTherapeutics, a clinical-stage company developing immunotherapeutic drugs, announced that its Chief Medical Officer, Richard Kenney, M.D., will present at the 6th Annual Cytokine-Based Drug Development Summit. The presentation will focus on managing toxicity caused by the overexpression of cytokines to widen the therapeutic window.

  GlobeNewswire Inc.
• Sonnet BioTherapeutics Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

  Sonnet BioTherapeutics, a clinical-stage biotech company, announced a $3.9 million registered direct offering and concurrent private placement. The proceeds will be used for research, development, and general corporate purposes.

  GlobeNewswire Inc.
• Dow Falls Over 100 Points; Alphabet Shares Tumble After Q3 Results

  U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 100 points on Wednesday. The Dow traded down 0.35% to 33,025.71 while the NASDAQ fell 2.45% to 12,817.76. The S&P 500 also fell, dropping, 1.48% to 4,184.98. Check This Out: How To Earn $500 A Month From Coca-Cola Stock After Better-Than-Expected Earnings   Leading and Lagging Sectors   Consumer staples shares rose by 0.3% on Wednesday. In trading on Wednesday, communication services shares dipped by 5.9%.   Top Headline   Alphabet Inc (NASDAQ: GOOGL) shares fell around 10% on Wednesday on the heels of the company's third-quarter financial results. Alphabet said revenue increased 11% year-over-year to $76.69 billion, which beat the consensus estimate of $75.94 billion. The company reported quarterly earnings of $1.55 per share, which also beat analyst estimates. However, the company recorded downbeat performance for its cloud computing unit.   Equities Trading UP   Abri SPAC I, Inc. (NASDAQ: ASPA) shares shot up 122% to $27.75 after the company announced its stockholders approved of the proposed merger with DLQ, Inc. Shares of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) got a boost, shooting 21% to $2.84 after announcing positive ...

  Benzinga

  Featured Companies: BTAI GOOGL LRN VICR
• Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

  Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ. Nuvve Holding Corp. (NASDAQ: NVVE) shares climbed 88% to $0.2789 after falling 10% on Tuesday. Nuvve recently announced pricing of a $1 million underwritten public offering of roughly 7 million shares of common stock at a price to the public of $0.14 per share. BIO-key International, Inc. (NASDAQ: BKYI) surged 57% to $0.30. BIO-key International reported results for its third quarter ended Sept. 30, 2023. ReShape Lifesciences Inc. (NASDAQ: RSLS) gained 44.7% to $0.2976 after gaining over 6% on Tuesday. ReShape Lifesciences recently announced pricing of $3.0 million public offering. BioXcel Therapeutics, Inc. (NASDAQ: BTAI) shares climbed 37.6% to $3.2199 after announcing positive findings from an independent third party audit of the data integrity at TRANQUILITY II Phase 3 trial site. ParaZero Technologies Ltd. (NASDAQ: PRZO) gained 26% to $2.0350. Catalyst Biosciences, Inc. (NASDAQ: CBIO) climbed 18% to $0.5095. Scholar Rock Holding Corporation (NASDAQ: SRRK) gained 16.5% to $8.92. Jefferies upgraded Scholar Rock from Hold to Buy and announced a $20 price target. Stride, Inc. (NYSE: LRN) rose 16.4% to $51.81 after the company reported first-quarter results. OncoCyte Corporation (NASDAQ: OCX) gained 14.4% to $2.86. Urgent.ly Inc. (NASDAQ: ULY) surged 14% to $5.01. GameSquare Holdings, Inc. (NASDAQ: GAME) gained 13.1% to $2.07. Treasure Global Inc. (NASDAQ: TGL) rose 12.8% to $0.4501. PROG Holdings, Inc. (NYSE: PRG) rose 9.3% to $31.14 following upbeat quarterly results. LumiraDx Limited (NASDAQ: LMDX) gained 8.4% to $0.1680 after dipping around 44% on Tuesday. John Bean Technologies Corporation (NYSE: JBT) surged 8.1% to $104.00 after posting strong quarterly earnings. Sonendo, Inc. (NYSE: SONX) shares gained 8% to $0.2483 after falling over 23% on Tuesday. Sonendo recently announced preliminary revenue results for the third quarter. Crown ElectroKinetics Corp. (NASDAQ: CRKN) climbed 8% to $0.2700. Deutsche Bank Aktiengesellschaft (NYSE: DB) rose 6.6% to $10.72 after the company reported a year-over-year increase in third-quarter EPS and sales results. Deutsche Bank Aktiengesellschaft (NYSE: DB) gained 6.6% to $10.72 after the company reported a year-over-year increase in third-quarter EPS and sales results. The Gap, Inc. (NYSE: GPS) climbed 6.2% ...

  Benzinga

  Featured Companies: ADP AFRM AIRE ALKS ASTI ATEC BIVI BKYI BOKF BTAI BYD CBUS CGTX CSGP CSTM DB DDD ENVA ERII GAME GBX GOOGL IDYA INM INTZ LEDS LIPO LRN LTH MKTX MPX MSFT NVVE OC OCX OPCH PRG PRZO RGEN RSLS SPWR SRRK SSYS TDOC TGL THAR TXN ULY USNA VICR YOSH
• Crude Oil Edges Higher; Thermo Fisher Scientific Cuts FY23 Forecast

  U.S. stocks traded mostly lower midway through trading, with the Nasdaq Composite falling more than 150 points on Wednesday. The Dow traded up 0.20% to 33,206.51 while the NASDAQ fell 1.76% to 12,908.76. The S&P 500 also fell, dropping, 0.92% to 4,208.77. Check This Out: How To Earn $500 A Month From Coca-Cola Stock After Better-Than-Expected Earnings   Leading and Lagging Sectors   Utilities shares rose by 0.5% on Wednesday. In trading on Wednesday, communication services shares fell by 4.7%.   Top Headline   Thermo Fisher Scientific Inc. (NYSE: TMO) reported mixed third-quarter financial results and lowered its FY23 guidance. Thermo Fisher Scientific posted adjusted earnings of $5.69 per share, versus expectations of $5.61 per share. The company’s sales came in at $10.57 billion, compared to estimates of $10.59 billion.   Equities Trading UP   Abri SPAC I, Inc. (NASDAQ: ASPA) shares shot up 117% to $27.10 after the company announced its stockholders approved of the proposed merger with DLQ, Inc. Shares of BIO-key International, Inc. (NASDAQ: BKYI) got a boost, shooting 31% to $0.2497 following third-quarter results. Stride, Inc. (NYSE: LRN) shares ...

  Benzinga

  Featured Companies: BKYI LRN TMO VICR